Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy

F Cofano, M Boido, M Monticelli, F Zenga… - International journal of …, 2019 - mdpi.com
Spinal cord injury (SCI) constitutes an inestimable public health issue. The most crucial
phase in the pathophysiological process of SCI concerns the well-known secondary injury …

Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

FG Teixeira, MM Carvalho, N Sousa… - Cellular and Molecular …, 2013 - Springer
The low regeneration potential of the central nervous system (CNS) represents a challenge
for the development of new therapeutic strategies. Mesenchymal stem cells (MSCs) have …

Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species

J Su, X Chen, Y Huang, W Li, J Li, K Cao… - Cell Death & …, 2014 - nature.com
Mammalian mesenchymal stem cells (MSCs) have been shown to be strongly
immunosuppressive in both animal disease models and human clinical trials. We have …

Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants

CS Lin, G Lin, TF Lue - Stem cells and development, 2012 - liebertpub.com
Mesenchymal stem cells (MSCs) are well known for their immunomodulatory capabilities. In
particular, their immunosuppressive property is believed to permit their allogeneic or even …

Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: systematic review with meta-analyses of rat models

RS Oliveri, S Bello, F Biering-Sørensen - Neurobiology of disease, 2014 - Elsevier
Traumatic spinal cord injury (SCI) is a devastating event with huge personal and societal
costs. A limited number of treatments exist to ameliorate the progressive secondary damage …

Coenzyme Q10 Regulation of Apoptosis and Oxidative Stress in H2O2 Induced BMSC Death by Modulating the Nrf‐2/NQO‐1 Signaling Pathway and Its Application …

X Li, J Zhan, Y Hou, Y Hou, S Chen… - Oxidative medicine …, 2019 - Wiley Online Library
Spinal cord injury (SCI) has always been considered to be a devastating problem that
results in catastrophic dysfunction, high disability rate, low mortality rate, and huge cost for …

Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans

JH Park, DY Kim, IY Sung, GH Choi, MH Jeon… - …, 2012 - journals.lww.com
BACKGROUND: Although the transplantation of mesenchymal stem cells (MSCs) after
spinal cord injury (SCI) has shown promising results in animals, less is known about the …

Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery

M Swaminathan, M Stafford-Smith… - Journal of the …, 2018 - journals.lww.com
AKI after cardiac surgery remains strongly associated with mortality and lacks effective
treatment or prevention. Preclinical studies suggest that cell-based interventions may …

The role of mesenchymal stem cells (MSCs) in veterinary medicine and their use in musculoskeletal disorders

P Prządka, K Buczak, E Frejlich, L Gąsior, K Suliga… - Biomolecules, 2021 - mdpi.com
Regenerative medicine is a dynamically develo** field of human and veterinary medicine.
The animal model was most commonly used for mesenchymal stem cells (MSCs) treatment …

Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury

Z Zhou, Y Chen, H Zhang, S Min, B Yu, B He, A ** - Cytotherapy, 2013 - Elsevier
Background aims Bone marrow and subcutaneous adipose tissue are both considered
prospective sources of mesenchymal stromal cells (MSCs), which can be used in cell …